Page last updated: 2024-09-03

a 68930 and Acute Kidney Injury

a 68930 has been researched along with Acute Kidney Injury in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Cao, JY; Li, ZL; Liu, BC; Liu, H; Yang, Y; Zhou, LT	1

Other Studies

1 other study(ies) available for a 68930 and Acute Kidney Injury

Article	Year
Dopamine D1 receptor agonist A68930 attenuates acute kidney injury by inhibiting NLRP3 inflammasome activation. Journal of pharmacological sciences, 2020, Volume: 143, Issue:3 Topics: Acute Kidney Injury; Animals; Chromans; Disease Models, Animal; Down-Regulation; Inflammasomes; Inflammation Mediators; Interleukin-1beta; Interleukin-6; Kidney; Male; Mice, Inbred C57BL; NLR Family, Pyrin Domain-Containing 3 Protein; Receptors, Dopamine D1; Reperfusion Injury; Tumor Necrosis Factor-alpha	2020

Article

Year

Dopamine D1 receptor agonist A68930 attenuates acute kidney injury by inhibiting NLRP3 inflammasome activation.

Journal of pharmacological sciences, 2020, Volume: 143, Issue:3

Topics: Acute Kidney Injury; Animals; Chromans; Disease Models, Animal; Down-Regulation; Inflammasomes; Inflammation Mediators; Interleukin-1beta; Interleukin-6; Kidney; Male; Mice, Inbred C57BL; NLR Family, Pyrin Domain-Containing 3 Protein; Receptors, Dopamine D1; Reperfusion Injury; Tumor Necrosis Factor-alpha

2020